Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials
1 study found for:    19075262 [PUBMED-IDS]
Show Display Options
Rank Status Study
1 Completed
Has Results
Safety and Efficacy Study of Tarceva, Temodar, and Radiation Therapy in Patients With Newly Diagnosed Brain Tumors
Conditions: Glioblastoma Multiforme;   Gliosarcoma
Interventions: Drug: Tarceva;   Drug: Temodar;   Procedure: Radiation Therapy

Indicates status has not been verified in more than two years